Program Barcelona

'Science Based Patenting and Licensing'

Thursday 11 October 2001

 
09.00  David Owen, President ASTP

         Opening

09.10  Carles Sola, Rector Universidad Autonoma de Barcelona & Board member European University Association

         Welcome

09.30  Leo Polz, Partner Hoffman Eitle, Germany
New Claim Types for Biotech and Pharmaceutical Inventions

10.00  DeAnn Smith, Partner Lahive and Cockfield LLP, USA
Patenting in the Post-Genomics Era

10.30  Discussion

10.45 – 11.15 BREAK

11.15  Sue Scott, Head of Patents BTG, United Kingdom
Patent Strategies for Universities

11.45  Vincent Ryckaert, Patent Officer IMEC, Belgium
Protecting Software

12.15  Discussion

12.45 – 13.45 LUNCH

13.45  Friederike Stolzenburg, Patent Attorney Vossius & Partner, Germany
Patentability of Research Tools

14.15  Philippe Ducor, Attorney, Physician B.M.G. Avocats, Switzerland
Experimental Use Exemption

14.45  Discussion

15.15– 15.30 BREAK

15.30  David Morgan, Assistant Director of Marketing UK Patent Office, United Kingdom
Ownership of intellectual Property

16.00  Remco de Ranitz, Attorney at Law Arnold & Siedsma, the Netherlands
Dealing with Infringement and Enforcement

16.30  Discussion

17.00 – 18.30 COCKTAIL (hosted by Arnold & Siedsma)

19.00 SOCIAL PROGRAM (Optional)
 

Friday 12 October 2001

09.00  Karen Hersey, Senior Counsel for Intellectual Property Massachusetts Institute of Technology, USA
         Optimizing Asset Potential through Careful Licensing

09.30  Morag Macdonald, Partner and Head of International IP Group, Bird & Bird, United Kingdom
Key Legal Issues and Pitfalls for Universities when Licensing

10.00  Discussion

10.30 – 11.00 BREAK

11.00  James Marshall, Partner, Intellectual Property Department, Taylor Joynson Garrett, United Kingdom
Licensing Research Tools

11.30  Eric Baas, Managing Director, Creative BioVentures, Switzerland
Commercializing Databases

12.00  Discussion

12.30 – 13.30 LUNCH

13.30  Mark Edwards, Managing Director Recombinant Capital, USA
Valuation and Structuring Considerations: equity, royalty and running royalty

14.15  Discussion

14.30 – 15.00 BREAK

15.00  ROLE PLAY
Attendees will participate in one of the following role-plays:
I. ‘Out-licensing or Spin-offs ?’
II. ‘Exclusive versus non-exclusive Licenses’
The results of the brainstorm sessions, lead by experienced tech transfer managers, will be plenary discussed.

16.30 RECEPTION & CLOSURE